Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hypertension
Interventions
DRUG

Fimasartan

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Yonsei University

OTHER

collaborator

Cheil General Hospital and Women's Healthcare Center

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT00923611 - Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients | Biotech Hunter | Biotech Hunter